Multiple Myeloma Never Gives Up. But Neither Do We. Trademark Details

Multiple Myeloma Never Gives up. but Neither DO We. was registered on Tuesday, November 12, 2013 and is currently owned by Celgene Corporation under the registration number 4432573 . This mark is alive with a status of Registered. The last case file activity for this mark occured 10 years ago on Tuesday, November 12, 2013, according to the United State Patent & Trademark Office
Word Mark Multiple Myeloma Never Gives up. but Neither DO We.
Status Alive Registered 700 — Registered

Current Owner

Celgene Corporation of Summit, NJ

View all trademarks for Celgene Corporation
Other Trademarks for Celgene Corporation
Serial Number 85915816
Registration Number 4432573
Status Date Tuesday, November 12, 2013
Filing Date Tuesday, November 12, 2013
Registration Date Tuesday, November 12, 2013
Attorney Camille M. Miller

Correspondent

CAMILLE M. MILLER
COZEN O'CONNOR
One Liberty Place
1650 MARKET ST
PHILADELPHIA PA 19103

Case File Statements

Indication of Colors The color(s) light blue, dark blue, white and gray is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text "Multiple Myeloma"
Description of Mark The mark consists of "MULTIPLE MYELOMA NEVER GIVES UP." in light blue with a dark blue background. The graph is shown in white, blue and gray. "BUT NEITHER DO WE." at the bottom in white.
Goods & Services Development and testing services in the fields of biotechnology, chemistry and pharmaceuticals; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services for medical and scientific research and development purposes, namely, pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific research services; scientific research, namely, development of pharmaceuticals or diagnostic methods for others

Classifications

International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 6 — Active
Status Date Friday, May 3, 2013
First Use Anywhere Sunday, July 1, 2012
First Use In Commerce Sunday, July 1, 2012
Primary Code 042

You must be signed in to print.

Once signed in, look for the PDF button.